for the first-line treatment of adults with recurrent or metastatic nonkeratinizing nasopharyngeal carcinoma (NPC); or as a single agent, for the treatment of adults with metastatic ...

Approval of penpulimab-kcqx marks the company’s US regulatory debut and introduces a new immunotherapy option for advanced nasopharyngeal carcinoma. The FDA has approved Akeso’s penpulimab-kcqx, a ...

in combination with cisplatin or carboplatin and gemcitabine for the first-line treatment of adult recurrent or metastatic non-keratinizing nasopharyngeal carcinoma (NPC). The FDA also approved ...

AUGUSTA, Ga. (WJBF)-The average age for someone diagnosed with Kidney Cancer in the U.S. is 65. But one local man’s decades-long battle with cancer began before he was even 10 years old.

The FDA has approved penpulimab-kcqx with chemotherapy and as a single agent for some patients with nasopharyngeal carcinoma. The United States Food and Drug Administration (FDA) has approved ...

The FDA has approved penpulimab with chemotherapy for first-line recurrent/metastatic non-keratinizing nasopharyngeal carcinoma and alone after prior treatment. The FDA approved penpulimab-kcqx in ...

Ki-67 is a protein found in the nucleus of cancer cells that are actively growing and dividing. For breast cancer, Ki-67 is one of the main tumor biomarkers that your healthcare provider will check ...

Keratinocyte carcinoma, including BCCs and cutaneous SCCs, is the most common cancer with a continuous rise in incidence. SCCs show a 49.3% objective response rate to PD-1 therapy, while ...

UTUC affects 1-2 per 100,000 people in the U.S., representing 6% of urothelial carcinoma cases, with symptoms like hematuria and urinary obstruction. Treatment strategies for UTUC depend on tumor ...

Adrenal carcinoma is a rare form of cancer that occurs when healthy cells in the adrenal glands mutate and grow out of control. The adrenal glands are two small organs located above each of the ...

and its high expression is associated with poor prognosis in hepatocellular carcinoma (HCC) patients. However, the mechanistic role of PCNA in HCC progression remains poorly understood. This study ...